Latest Drugs Stories
Romosozumab Currently in Phase 3 Clinical Development, Pivotal Data Expected in 2016 THOUSAND OAKS, Calif. and BRUSSELS, Sept.
Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif., Sept.
Company Receives Purchase Order for its Rx DrugSAFE Fingerprint Lock-boxes HENDERSON, Nev., Sept.
Industry consolidation will continue to increase the size and clout of PBMs who promote drug therapies as preventative measures and less expensive alternatives to more costly forms of medical
ST. PAUL, Minn., Sept.
The NCPA recently wrote to the U.S. House of Representatives and encouraged them to pass a bill that would make great strides in reducing the number of Americans misusing prescription drugs.
Session to Provide Solutions to the Healthcare Professionals Treating Mild-to-Moderate Pain LAS VEGAS, Sept.
Harbor Village Florida Comments On Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults USA (PRWEB) August 29, 2014 According to new
Company prepares to battle prescription drug abuse in the home HENDERSON, Nev., Aug.
Current Prescribers of Biosimilars Choose Between Biosimilar Products Based on the Manufacturer, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.